Salvatore Del Prete

Also affiliated with Etna Biotech (Italy), Kai Biotech (South Korea)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium”.

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

The Lancet Regional Health - Americas(2023)10.1016/j.lana.2023.100445

N/A

0DataRank · unranked

39 citations

Chris Labaki, Ziad Bakouny, Chih–Yuan Hsu, Andrew Schmidt, Gilberto Lopes +39 more

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

UNC Libraries(2025)10.17615/bna9-v350

N/A

0DataRank · unranked

0 citations

Sanjay Mishra, Karen Russell, Samuel M. Rubinstein, Blau, Sibel, Daniel Y. Reuben +39 more